Spatial rectal dose/volume metrics predict patient-reported gastro-intestinal symptoms after radiotherapy for prostate cancer

References

• Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–1403.
   PubMed Web of Science ®Google Scholar
• Fosså SD, Wiklund F, Klepp O, et al. Ten- and 15-yr prostate cancer-specific mortality in patients with nonmetastatic locally advanced or aggressive intermediate prostate cancer, randomized to lifelong endocrine treatment alone or combined with radiotherapy: final results of the Scandinavian Prostate Cancer Group-7. Eur Urol. 2016;70:684–691.
   PubMed Web of Science ®Google Scholar
• Peeters STH, Heemsbergen WD, Koper PCM, et al. Dose–response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol. 2006;24:1990–1996.
   PubMed Web of Science ®Google Scholar
• Nguyen Q-N, Levy LB, Lee AK, et al. Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation. Cancer. 2013;119:3265–3271.
   PubMed Web of Science ®Google Scholar
• Heemsbergen WD, Al-Mamgani A, Slot A, et al. Long-term results of the Dutch randomized prostate cancer trial: impact of dose-escalation on local, biochemical, clinical failure, and survival. Radiother Oncol. 2014;110:104–109.
   PubMed Web of Science ®Google Scholar
• Thor M, Olsson CE, Oh JH, et al. Relationships between dose to the gastro-intestinal tract and patient-reported symptom domains after radiotherapy for localized prostate cancer. Acta Oncol. 2015;54:1326–1334.
   PubMed Web of Science ®Google Scholar
• Budäus L, Bolla M, Bossi A, et al. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol. 2012;61:112–127.
   PubMed Web of Science ®Google Scholar
• Schaake W, Wiegman EM, de Groot M, et al. The impact of gastrointestinal and genitourinary toxicity on health related quality of life among irradiated prostate cancer patients. Radiother Oncol. 2014;110:284–290.
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Poon BY, Eastham J, et al. Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer. Radiother Oncol. 2016;118:85–91.
   PubMed Web of Science ®Google Scholar
• Petersen SE, Bentzen L, Emmertsen KJ, et al. Development and validation of a scoring system for late anorectal side-effects in patients treated with radiotherapy for prostate cancer. Radiother Oncol. 2014;111:94–99.
   PubMed Web of Science ®Google Scholar
• Michalski JM, Yan Y, Watkins-Bruner D, et al. Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial. Int J Radiat Oncol Biol Phys. 2013;87:932–938.
   PubMed Web of Science ®Google Scholar
• Jackson A, Marks LB, Bentzen SM, et al. The lessons of QUANTEC: recommendations for reporting and gathering data on dose–volume dependencies of treatment outcome. Int J Radiat Oncol Biol Phys. 2010;76:S155–S160.
   PubMed Web of Science ®Google Scholar
• Michalski JM, Gay H, Jackson A, et al. Radiation dose–volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys. 2010;76:S123–S129.
   PubMed Web of Science ®Google Scholar
• Liu M, Moiseenko V, Agranovich A, et al. Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: a test of the QUANTEC-recommended NTCP model. Acta Oncol. 2010;49:1040–1044.
   PubMed Web of Science ®Google Scholar
• Maeda Y, Høyer M, Lundby L, et al. Faecal incontinence following radiotherapy for prostate cancer: a systematic review. Radiother Oncol. 2011;98:145–153.
   PubMed Web of Science ®Google Scholar
• Lund J-Å, Kaasa S, Wibe A, et al. Late radiation effects to the rectum and anus after treatment for prostate cancer; validity of the LENT/SOMA score. Acta Oncol. 2013;52:727–735.
   PubMed Web of Science ®Google Scholar
• Buettner F, Gulliford SL, Webb S, et al. The dose–response of the anal sphincter region – an analysis of data from the MRC RT01 trial. Radiother Oncol. 2012;103:347–352.
   PubMed Web of Science ®Google Scholar
• Heemsbergen WD, Hoogeman MS, Hart GAM, et al. Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2005;61:1011–1018.
   PubMed Web of Science ®Google Scholar
• Wortel RC, Witte MG, van der Heide UA, et al. Dose–surface maps identifying local dose-effects for acute gastrointestinal toxicity after radiotherapy for prostate cancer. Radiother Oncol. 2015;117:515–520.
   PubMed Web of Science ®Google Scholar
• Hamlett LJ, McPartlin AJ, Maile EJ, et al. Parametrized rectal dose and associations with late toxicity in prostate cancer radiotherapy. Br J Radiol. 2015;88:20150110.
   PubMed Web of Science ®Google Scholar
• Troeller A, Yan D, Marina O, et al. Comparison and Limitations of DVH-Based NTCP models derived from 3D-CRT and IMRT data for prediction of gastrointestinal toxicities in prostate cancer patients by using propensity score matched pair analysis. Int J Radiat Oncol Biol Phys. 2015;91:435–443.
   PubMed Web of Science ®Google Scholar
• Tucker SL, Zhang M, Dong L, et al. Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study. Int J Radiat Oncol Biol Phys. 2006;64:1255–1264.
   PubMed Web of Science ®Google Scholar
• Buettner F, Gulliford SL, Webb S, et al. Modeling late rectal toxicities based on a parameterized representation of the 3D dose distribution. Phys Med Biol. 2011;56:2103–2118.
   PubMed Web of Science ®Google Scholar
• Wald A, Wolfowitz J. Confidence limits for continuous distribution functions. Ann Math Stat. 1939;10:105–118.
   Google Scholar
• Agresti A, Coull BA. Approximate is better than “exact” for interval estimation of binomial proportions. Am Stat. 1998;52:119–126.
   Web of Science ®Google Scholar
• Snee RD. Validation of regression models: methods and examples on JSTOR. Technometrics. 1977;19:415–428.
   Web of Science ®Google Scholar
• Xu C-J, van der Schaaf A, Schilstra C, et al. Impact of statistical learning methods on the predictive power of multivariate normal tissue complication probability models. Int J Radiat Oncol Biol Phys. 2012;82:e677–e684.
   PubMed Web of Science ®Google Scholar
• Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.
   PubMed Web of Science ®Google Scholar
• Hosmer DW, Lemesbow S. Goodness of fit tests for the multiple logistic regression model. Commun Stat – Theory Methods. 1980;9:1043–1069.
   Web of Science ®Google Scholar
• Deasy JO, Blanco AI, Clark VH. CERR: a computational environment for radiotherapy research. Med Phys. 2003;30:979–985.
   PubMed Web of Science ®Google Scholar
• Naqa I El, Suneja G, Lindsay PE, et al. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose–volume outcome relationships. Phys Med Biol. 2006;51:5719–5735.
   PubMed Web of Science ®Google Scholar
• Nguyen PL, Chen RC, Hoffman KE, et al. Rectal dose–volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial. Int J Radiat Oncol Biol Phys. 2010;78:1081–1085.
   PubMed Web of Science ®Google Scholar
• Gulliford SL, Foo K, Morgan RC, et al. Dose–volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397. Int J Radiat Oncol Biol Phys. 2010;76:747–754.
   PubMed Web of Science ®Google Scholar
• Fiorino C, Fellin G, Rancati T, et al. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study. Int J Radiat Oncol Biol Phys. 2008;70:1130–1137.
   PubMed Web of Science ®Google Scholar
• Stenmark MH, Conlon ASC, Johnson S, et al. Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer. Radiother Oncol. 2014;110:291–297.
   PubMed Web of Science ®Google Scholar
• Cella L, D’Avino V, Liuzzi R, et al. Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer. Radiat Oncol. 2013;8:221.
   PubMed Web of Science ®Google Scholar
• Vanasek J, Odrazka K, Dolezel M, et al. Statistical analysis of dose–volume profiles and its implication for radiation therapy planning in prostate carcinoma. Int J Radiat Oncol Biol Phys. 2013;86:769–776.
   PubMed Web of Science ®Google Scholar
• Ospina JD, Zhu J, Chira C, et al. Random forests to predict rectal toxicity following prostate cancer radiation therapy. Int J Radiat Oncol Biol Phys. 2014;89:1024–1031.
   PubMed Web of Science ®Google Scholar
• Thor M, Apte A, Deasy JO, et al. Dose/volume-response relations for rectal morbidity using planned and simulated motion-inclusive dose distributions. Radiother Oncol. 2013;109:388–393.
   PubMed Web of Science ®Google Scholar
• Petersen SE, Bregendahl S, Langschwager M, et al. Pathophysiology of late anorectal dysfunction following external beam radiotherapy for prostate cancer. Acta Oncol. 2014;53:1398–1404.
   PubMed Web of Science ®Google Scholar
• Casares-Magaz O, Thor M, Liao D, et al. An image-based method to quantify biomechanical properties of the rectum in radiotherapy of prostate cancer. Acta Oncol. 2015;54:1335–1342.
   PubMed Web of Science ®Google Scholar
• Smeenk RJ, Hopman WPM, Hoffmann AL, et al. Differences in radiation dosimetry and anorectal function testing imply that anorectal symptoms may arise from different anatomic substrates. Int J Radiat Oncol Biol Phys. 2012;82:145–152.
   PubMed Web of Science ®Google Scholar